Internal Reference Number: FOI_6555
Date Request Received: 14/04/2022 00:00:00
Date Request Replied To: 27/04/2022 00:00:00
This response was sent via: By Email
Request Summary: Asthma
Request Category: Companies
| Question Number 1: How many patients have been treated (for any condition) in the last 4 months with: • Benralizumab • Omalizumab • Reslizumab • Mepolizumab | |
| Answer To Question 1: 18 patients have been treated with Omalizumab. 0 for all others | |
| Question Number 2: Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups: • Age 6-11 • Age 12-17 • Age 18 and above | |
| Answer To Question 2: All 18 patients were 18 and above | |
| Question Number 3: How many patients have been treated in the last four months with Dupilumab for Asthma ONLY? | |
| Answer To Question 3: The trust has not used dupilumab for Asthma. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
